Fourth Order Derivative Spectrophotometric Determination of Benzyl Alcohol in Piroxicam Injections

Piroxicam is a drug with analgesic and anti‐inflammatory properties. It is present in numerous pharmaceutical preparations. Injectable forms usually contain benzyl alcohol as an excipient, which is used as a blocking anesthetic (4%) and an antiseptic (4–10%). In this work, spectrophotometric methodology was used in order to determine benzyl alcohol in piroxicam injectable formulations by applying the fourth derivative method adopting the zero‐crossing technique. The results obtained show that the method has significant advantages over other reported methods and is appropriate for routine pharmaceutical analysis. The method showed excellent linearity in the range of 2–100 μg mL^?1 with limit of detection (S/N = 3) 0.07 μg mL^?1 (6.47 × 10^?7 M). The proposed method could be applied successfully for the determination of benzyl alcohol in injectable formulations with average % recovery of 100 ± 0.61.     

Determination of Piroxicam in Pharmaceutical Formulations Combining Amperometry and Multicommutation

This work describes the development of a multicommutated flow system with amperometric detection, applied in the determination of piroxicam in pharmaceutical formulations.     

Determination of potential degradation products of piroxicam by HPTLC densiometry and HPLC

Summary HPTLC densitometry and HPLC are considered for the simultaneous determination of the degradation products of piroxicam (2-aminopyridine, DP-I and DP-II). The substances were separated on silica gel with fluorescence indicator in ethylacetate — toluene — diethylamine (10∶10∶5) and toluene — absolute ethanol — glacial acetic acid (8∶1.2∶0.5) systems. The measuring absorbance (detection of reflectance) of the separated substances was carried out “in situ” at 296 nm using 4-level calibration (external standard, nonlinear regresson function) in the concentration range 600–1200 ng 2-aminopyridine/spot and 300–600 ng DP-I and DP-II/spot. The HPLC method was carried out using RP-8 stationary phase and methanol + phosphate-citrate buffer, pH 3 mobile phase with addition of sodium pentanesulfonate (40+60, v/v). 2-aminopyridine wass detected at 300 nm, DP-I at 280 nm and DP-II at 248 nm. The concentration range for 2-aminopyridine is 2–40 μg/ml, for DP-I and DP-II 2–20 μg/ml (for an injection volume of 10 μl). The results were evaluated by linear regression analysis.     

Ultrasound influence on the solubility of solid dispersions prepared for a poorly soluble drug

Solid dispersions have been successfully used to enhance the solubility of several poorly water soluble drugs. Solid dispersions are produced by melting hydrophilic carriers and mixing in the poorly water soluble drug. Supersaturation is obtained by quickly cooling the mixture until it solidifies, thereby entrapping the drug. The effects of using ultrasound to homogenize the molten carrier and drug mixture were studied. In particular, the increase in drug solubility for the resulting solid dispersions was analyzed. Piroxicam, which has very low water solubility, was used as a model drug. A full factorial design was used to analyze how sonication parameters affected the solubility and in vitro release of the drug. The results show that the use of ultrasound can significantly increase the solubility and dissolution rate of the piroxicam solid dispersion. Pure piroxicam presented a solubility of 13.3 μg/mL. A maximum fourfold increase in solubility, reaching 53.8 μg/mL, was observed for a solid dispersion sonicated at 19 kHz for 10 min and 475 W. The in vitro dissolution rate test showed the sonicated solid dispersion reached a maximum rate of 18%/min, a sixfold increase over the piroxicam rate of 2.9%/min. Further solid state characterization by thermal, X-ray diffraction and Fourier transform infrared analyses also showed that the sonication process, in the described conditions, did not adversely alter the drug or significantly change its polymorphic form. Ultrasound is therefore an interesting technique to homogenize drug/carrier mixtures with the objective of increasing the solubility of drugs with poor water solubility.     

The interactions of metal ions with nonsteroidal anti-inflammatory drugs (oxicams)

Much work has been focused on interactions of metal ions with nonsteroidal anti-inflammatory drugs (oxicams). Numerous attempts to synthesize several metal complexes have been published. This review highlights the synthesis and properties of the synthesized metal complexes. Different physico-chemical methods (IR, UV–Vis, measurement, thermal analysis, and NMR spectroscopy) as well as the bioactivity of the metal compounds are mentioned.     

Study on inclusion interaction of piroxicam with beta-cyclodextrin derivatives

The inclusion behavior of piroxicam (PX) with beta-cyclodextrin (beta-CD), hydroxypropyl-beta-cyclodextrin (HP-beta-CD), and carboxymethyl-beta-cyclodextrin (CM-beta-CD) was investigated by using steady-state fluorescence and nuclear magnetic resonance (NMR) technique. The various factors affecting the inclusion process were examined in detail. The remarkable fluorescence emission enhancement upon addition of CDs suggested that cyclodextrins (CDs) were most suitable for inclusion of the uncharged species of PX. The stoichiometry of the PX-CDs inclusion complexes was 1:1, except for beta-CD where a 1:2 inclusion complex was formed. The formation constants showed the strongest inclusion capacity of beta-CD. NMR showed the inclusion mode of PX with CDs.     

Spectrofluorimetric Determination of Piroxicam in Pharmaceutical Preparations and Spiked Human Serum Using Micellar Media

The fluorescence properties of piroxicam in various micellar media were investigated. It was found that the presence of 0.05M sodium dodecyl sulfate (SDS) surfactant (pH 1.5–2, nitric acid) causes an approximately 5-fold enhancement in the fluorescence of this drug. An experimental design approach based on central composite design was used to investigate the influence of the main variables (pH, SDS concentration and temperature) on the fluorescence signal. Based on the obtained results, a micelle-enhanced fluorescence method was developed for the determination of piroxicam in pharmaceuticals and also in spiked human serum (after extraction with diethyl ether). The linear calibration ranges of the methods were 0.05–1.5 and 0.2–10µgmL^–1 for aqueous solution and serum samples, respectively. The detection limits were 0.015 and 0.10µgmL^–1 in aqueous and serum samples, respectively.Received November 24, 2002; accepted April 13, 2003 Published online August 8, 2003     

Femtosecond dynamics of a non-steroidal anti-inflammatory drug (piroxicam) in solution: The involvement of twisting motion

In this contribution, we report on fast and ultrafast dynamics of a non-steroidal anti-inflammatory drug, piroxicam (PX), in methyl acetate (MAC) and triacetin (TAC), two solvents of different viscosities. The enol form of PX undergoes a femtosecond (shorter than 100 fs) electronically excited state intramolecular proton-transfer reaction to produce keto tautomers. These structures exhibit an internal twisting motion to generate keto rotamers in 2–5 ps, a time being longer in TAC. The transient absorption/emission spectrum is very broad indicating that the potential-energy surface at the electronically excited state is very flat, and reflecting the involvement of several coordinates along which the wavepacket of the fs-produced structures evolve.     

Bioisosteric hybrids of two anti-inflammatory agents, rutaecarpine and piroxicam

Bioisosteric replacements were accomplished by building the structural elements of piroxicam, an anti-inflammatory drug, into the pentacyclic system of rutaecarpine, a quinazolinocarboline alkaloid, in order to modify activity and selectivity on COX-isoenzymes. The pentacyclic compounds were synthesized efficiently by employing 1-oxo-9,10,11,12-tetrahydro-4H-pyrido[1,2-b]1,2-benzothiazine 5,5-dioxide as a key intermediate, and prepared by alternative routes. Condensation of the tricyclic ketone with arylhydrazines and subsequent Fischer-indolization provided the first representatives of new heterocyclic ring systems 3 and 4.     

A Sensitive Simultaneous Determination of Epinephrine and Piroxicam Using a Glassy Carbon Electrode Modified with a Nickel Hydroxide Nanoparticles/Multiwalled Carbon Nanotubes Composite

The electrooxidation of epinephrine (EPI) and piroxicam (PRX) has been investigated by application of nickel hydroxide nanoparticles/multiwalled carbon nanotubes composite electrode (MWCNTs‐NHNPs/GCE) using cyclic voltammetry (CV), differential pulse voltammetry (DPV) and chronoamperometry (CA) methods. The modified electrode showed suitable electrochemical responses for EPI and PRX determination. Under the optimum conditions the electrode provides a linear response versus EPI and PRX concentrations in the range of 1–220 µM and 0.7–75 µM, respectively using the DPV method. Linear responses versus EPI and PRX concentrations in the range of 1–1000 µM and 1–800 µM, respectively, were obtained using the CA method. The modified electrode was used for determination of EPI and PRX in human urine with satisfactory results.